Handelsavisen
prelaunch
Companies Healthcare AMRN.NS
AM
AMRN.NS NSE (India) Pharmaceuticals & Medical Research

ADF Foods Ltd

$270,30
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,45 %
Op margin
13,6 %
ROE
14,1 %
Net margin
11,7 %
Debt / equity
0,12
Beta
52w range
Volume
Day range
Prev close
$14,30
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

ADF Foods Ltd is a food processing company that generates revenue primarily through the production and sale of food products.

Business. ADF Foods Ltd (AMRN.NS) is an Indian food processing company listed on the National Stock Exchange of India. The firm operates within the Consumer Non-Cyclicals sector, specifically focusing on the Food & Beverages industry. As detailed segment and geographic data are unavailable, the company is described at the industry level as a participant in the food processing market. Its primary business activity involves the processing and sale of food products.

Classification99 %
SectorHealth Care
Industry groupPharmaceuticals & Medical Research
Generated · model-assisted
Sell-side consensus
HOLD2 analysts
0 buy1 hold1 sell
Avg 12m price target12,00

Analyst recommendations

2 analysts · consensus Hold
Buy0
Hold1
Sell1
12-month price target
12,00
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Hold
2 analysts · indicative
Ownership
Morgan Stanley Smith Barney LLC
largest disclosed fund holder
Profitability
14,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning AMRN.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to AMRN.NS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    ADF Foods Ltd (AMRN.NS) is an Indian food processing company listed on the National Stock Exchange of India. The firm operates within the Consumer Non-Cyclicals sector, specifically focusing on the Food & Beverages industry. As detailed segment and geographic data are unavailable, the company is described at the industry level as a participant in the food processing market. Its primary business activity involves the processing and sale of food products.

    Classification99 %
    SectorHealth Care
    Industry groupPharmaceuticals & Medical Research
    AI synthesis
    GENERATED

    ADF Foods Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.12, indicating a strong equity position relative to liabilities. The company's liquidity is assessed as medium, with a current ratio of 5.71, suggesting it has sufficient short-term assets to cover its short-term obligations. However, the company has no cash and equivalents, and its net cash position is negative after subtracting total debt, which could pose a liquidity risk if cash flow from operations is disrupted.

    In terms of profitability, ADF Foods Ltd reports a return on equity (ROE) of 14.06% and a return on assets (ROA) of 11.02%, both of which are strong indicators of efficient use of equity and assets to generate profit. These metrics suggest the company is performing well compared to typical industry benchmarks for food processing firms, which often emphasize operational efficiency and cost control.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no geographic diversification provided in the available data. This lack of diversification could expose the company to regional economic or regulatory risks, though the specific impact is not quantified in the available data.

    Looking ahead, the company's growth trajectory is not explicitly outlined in the available data, but its operating cash flow of INR 374.16 million and free cash flow of INR 264.83 million suggest it has the capacity to fund operations and potentially reinvest in the business. The capital expenditure of INR -412.38 million indicates that the company is investing in its operations, which could support future growth.

    The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's low dilution risk is supported by the fact that basic and diluted shares outstanding are equal, indicating no imminent threat of share dilution. However, the negative net cash position after subtracting total debt is a key flag that could affect liquidity if not managed properly.

    Recent events and filings are not detailed in the available data, so no specific recent developments can be cited. The company's financial health appears to be stable, but ongoing monitoring of its liquidity and capital structure is recommended to ensure continued operational resilience.

    Key takeaways
    • ADF Foods Ltd has a strong equity position with a low debt-to-equity ratio of 0.12.
    • The company's ROE of 14.06% and ROA of 11.02% indicate efficient use of capital and assets.
    • ADF Foods Ltd has no cash and equivalents, and its net cash position is negative after subtracting total debt.
    • The company's liquidity is assessed as medium, with a current ratio of 5.71.
    • The company's revenue is concentrated in a single business segment, with no geographic diversification provided.
    • The company has a low dilution risk, as basic and diluted shares outstanding are equal.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $270,30
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $4.93B
    Net cash
    -$592.3M
    Current ratio
    5.7
    Debt / equity
    0.1
    ROA
    11.0%
    ROE
    14.1%
    Cash conversion
    54.0%
    CapEx / revenue
    -7.0%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    INDUSTRYSEGMENTCOMPANYHealthcareIndustryPharmaceuticals & Medical Research15,2B node revenueKLAR 23,0%BNTX 21,4%EXEL 15,2%MDGL 6,3%INSM 4,0%VCYT 3,4%MDXG 2,8%AVIR 2,3%Other 21,6%
    Source: company disclosures · own-taxonomy revenue-covered set · attribution: collision-suspect (indicative)AMRN 1,4% · rank #10 of 109

    Business relationships

    Business relationships21 disclosed relationships · 2 types · extracted from filings & disclosures
    Customers3
    ANON:CUST:AMRN.O:CustomerAANON:CUST:AMRN.O:CustomerACustomer88%Source ↗
    ANON:CUST:AMRN.O:CustomerBANON:CUST:AMRN.O:CustomerBCustomer88%Source ↗
    ANON:CUST:AMRN.O:CustomerCANON:CUST:AMRN.O:CustomerCCustomer88%Source ↗
    Subsidiaries18
    EX21:00c025111ea5EX21:00c025111ea5Subsidiarie97%
    EX21:015250406908EX21:015250406908Subsidiarie97%
    EX21:1842826d0a1fEX21:1842826d0a1fSubsidiarie97%
    EX21:1d84000ca03fEX21:1d84000ca03fSubsidiarie97%
    EX21:2317ef1d486bEX21:2317ef1d486bSubsidiarie97%
    EX21:3e5175ae3370EX21:3e5175ae3370Subsidiarie97%
    EX21:40d92477dc3bEX21:40d92477dc3bSubsidiarie97%
    EX21:4309583edb89EX21:4309583edb89Subsidiarie97%
    EX21:54292cd72cddEX21:54292cd72cddSubsidiarie97%
    EX21:8a95494687a4EX21:8a95494687a4Subsidiarie97%
    EX21:9b675c4470b0EX21:9b675c4470b0Subsidiarie97%
    EX21:a8eb8d6c7499EX21:a8eb8d6c7499Subsidiarie97%
    EX21:bf561d330afbEX21:bf561d330afbSubsidiarie97%
    EX21:c2b26286440bEX21:c2b26286440bSubsidiarie97%
    EX21:cb7cb8e080b3EX21:cb7cb8e080b3Subsidiarie97%
    EX21:d2170fd4e11bEX21:d2170fd4e11bSubsidiarie97%
    EX21:d39d0d4823f5EX21:d39d0d4823f5Subsidiarie97%
    EX21:dc694fd385b0EX21:dc694fd385b0Subsidiarie97%

    Supply chain

    Vendors → AMRN ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSAMRNAMRNADF Foods Ltd21 entitiesANON:CUST:AMRN.O:CustoANON:CUST:AMRN.O:CustoANON:CUST:AMRN.O:Custo
    3 mentions in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-07-04

    Peer comparison

    Peer comparison8 peers · vs AMRN · multiples and returns
    KL
    KLAR
    KLAR.ST
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    BN
    BNTX
    Biontech SE
    $92,25
    23,3B USD
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    EX
    EXEL
    Exelixis Inc
    $55,06
    14,7B USD
    P/E
    19,5x
    vs self
    Div yield
    vs self
    ROE
    40,4 %
    +48,9 vs self
    MD
    MDGL
    Madrigal Pharmaceuticals Inc
    $482,00
    11,0B USD
    P/E
    vs self
    Div yield
    vs self
    ROE
    -47,8 %
    -39,4 vs self
    IN
    INSM
    Insmed Inc
    $107,46
    23,0B USD
    P/E
    vs self
    Div yield
    vs self
    ROE
    -160,2 %
    -151,7 vs self
    VC
    VCYT
    Veracyte Inc
    $45,30
    3,6B USD
    P/E
    55,5x
    vs self
    Div yield
    vs self
    ROE
    5,1 %
    +13,5 vs self
    MD
    MDXG
    Mimedx Group Inc
    $4,27
    636,0M USD
    P/E
    11,1x
    vs self
    Div yield
    vs self
    ROE
    18,9 %
    +27,4 vs self
    AV
    AVIR
    Atea Pharmaceuticals Inc
    $4,61
    P/E
    vs self
    Div yield
    vs self
    ROE
    -57,5 %
    -49,0 vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    -0,03
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    2
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-16 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate8,70
    Revenueno estimateno estimate6,6B INR
    Operating incomeno estimateno estimate1,2B INR
    Full-year consensus mean (period as reported by source) · consensus in INR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy0
    Buy0
    Hold1
    Sell0
    Strong sell0
    12-month price target$222,00 · Median $222,00
    Low $222,00High $222,00
    Operating income · consensus1,2B INR
    EPS surprise
    −27,6 %
    reported vs consensus · miss
    Revenue surprise
    −10,9 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$12,00
    Mean$12,00
    Median$12,00
    High$12,00
    Spot$270,30
    −95.6 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin13,6 %Above P75
    Net Margin11,8 %Above P75
    ROE14,1 %Above P75
    Capex / Rev-7,0 %Below median
    D/E0,12Below median
    Cash Conv0,54Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 341 930 sh16 exercises · 14 grants12 insiders
    • Horn KeithDirector · Restricted Stock Unit → American Depositary SharesAcquired 838exercise · 2026-04-18
    • Sullivan Diane E.Director · Restricted Stock Unit → American Depositary SharesAcquired 838exercise · 2026-04-18
    • Odysseas Kostas DDirector · Restricted Stock Unit → American Depositary SharesAcquired 838exercise · 2026-04-18
    • Sterling Louis IIIDirector · Restricted Stock Unit → American Depositary SharesAcquired 838exercise · 2026-04-18
    • Cohen PaulDirector · Restricted Stock Unit → American Depositary SharesAcquired 838exercise · 2026-04-18
    • Bonfiglio Patrice EadonDirector · Restricted Stock Unit → American Depositary SharesAcquired 838exercise · 2026-04-18
    • O'Connor OliverDirector · Restricted Stock Unit → American Depositary SharesAcquired 838exercise · 2026-04-18
    • Fishman Peter L.SVP, CFO · Restricted Stock Unit → American Depositary SharesAcquired 125exercise · 2026-04-01
    • Ketchum Steven BEVP, Chief Scientific Officer · Restricted Stock Unit → American Depositary SharesAcquired 8 013grant · 2026-02-01
    • Fishman Peter L.SVP, CFO · Stock Option (right to buy) → American Depositary SharesAcquired 27 750 @ $14,99grant · 2026-02-01
    • Fishman Peter L.SVP, CFO · Restricted Stock Unit → American Depositary SharesAcquired 6 167grant · 2026-02-01
    • Provoost JonathanEVP, Chief Legal Officer · Stock Option (right to buy) → American Depositary SharesAcquired 36 060 @ $14,99grant · 2026-02-01
    • Provoost JonathanEVP, Chief Legal Officer · Restricted Stock Unit → American Depositary SharesAcquired 8 013grant · 2026-02-01
    • Berg AaronPresident and CEO · Stock Option (right to buy) → American Depositary SharesAcquired 120 566 @ $14,99grant · 2026-02-01
    • Berg AaronPresident and CEO · Restricted Stock Unit → American Depositary SharesAcquired 26 793grant · 2026-02-01
    • Ketchum Steven BEVP, Chief Scientific Officer · Stock Option (right to buy) → American Depositary SharesAcquired 36 060 @ $14,99grant · 2026-02-01
    • Keenan David PaulEVP, Chief Operating Officer · Restricted Stock Unit → American Depositary SharesAcquired 8 013grant · 2026-02-01
    • Keenan David PaulEVP, Chief Operating Officer · Stock Option (right to buy) → American Depositary SharesAcquired 30 060 @ $14,99grant · 2026-02-01
    • Keenan David PaulEVP, Chief Operating Officer · Restricted Stock Unit → American Depositary SharesAcquired 2 246exercise · 2026-01-31
    • Keenan David PaulEVP, Chief Operating Officer · Restricted Stock Unit → American Depositary SharesAcquired 1 933exercise · 2026-01-31
    • Ketchum Steven BEVP, Chief Scientific Officer · Restricted Stock Unit → American Depositary SharesAcquired 1 933exercise · 2026-01-31
    • Berg AaronPresident and CEO · Restricted Stock Unit → American Depositary SharesAcquired 2 246exercise · 2026-01-31
    • Berg AaronPresident and CEO · Restricted Stock Unit → American Depositary SharesAcquired 1 933exercise · 2026-01-31
    • Fishman Peter L.SVP, CFO · Restricted Stock Unit → American Depositary SharesAcquired 563exercise · 2026-01-31
    • Fishman Peter L.SVP, CFO · Restricted Stock Unit → American Depositary SharesAcquired 1 833exercise · 2026-01-31

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • ADF Foods Ltd Market data — financials · 2026-05-27

    Ownership & reference

    Top holders

    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$4M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$0M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$0M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$0M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M

    Insider activity

    Mixed / flat0 buys · 0 sellsnet $012 insiders · last 365d
    • Bonfiglio Patrice EadonDirector · American Depositary SharesOther 403 @ $14,98$6K · 2026-04-18
    • Cohen PaulDirector · American Depositary SharesOther 838 · 2026-04-18
    • Cohen PaulDirector · American Depositary SharesOther 403 @ $14,98$6K · 2026-04-18
    • Sterling Louis IIIDirector · American Depositary SharesOther 838 · 2026-04-18
    • Sterling Louis IIIDirector · American Depositary SharesOther 403 @ $14,98$6K · 2026-04-18
    • Odysseas Kostas DDirector · American Depositary SharesOther 838 · 2026-04-18
    • Odysseas Kostas DDirector · American Depositary SharesOther 403 @ $14,98$6K · 2026-04-18
    • Sullivan Diane E.Director · American Depositary SharesOther 403 @ $14,98$6K · 2026-04-18
    • Horn KeithDirector · American Depositary SharesOther 838 · 2026-04-18
    • Horn KeithDirector · American Depositary SharesOther 403 @ $14,98$6K · 2026-04-18
    • O'Connor OliverDirector · American Depositary SharesOther 838 · 2026-04-18
    • O'Connor OliverDirector · American Depositary SharesOther 438 @ $14,98$7K · 2026-04-18
    • Sullivan Diane E.Director · American Depositary SharesOther 838 · 2026-04-18
    • Bonfiglio Patrice EadonDirector · American Depositary SharesOther 838 · 2026-04-18
    • Fishman Peter L.SVP, CFO · American Depositary SharesOther 125 · 2026-04-01
    • Fishman Peter L.SVP, CFO · American Depositary SharesOther 62 @ $14,46$897 · 2026-04-01
    • Keenan David PaulEVP, Chief Operating Officer · American Depositary SharesOther 1 173 @ $15,42$18K · 2026-01-31
    • Berg AaronPresident and CEO · American Depositary SharesOther 2 246 · 2026-01-31
    • Berg AaronPresident and CEO · American Depositary SharesOther 1 235 @ $15,42$19K · 2026-01-31
    • Berg AaronPresident and CEO · American Depositary SharesOther 1 933 · 2026-01-31
    • Berg AaronPresident and CEO · American Depositary SharesOther 1 063 @ $15,42$16K · 2026-01-31
    • Fishman Peter L.SVP, CFO · American Depositary SharesOther 563 · 2026-01-31
    • Fishman Peter L.SVP, CFO · American Depositary SharesOther 310 @ $15,42$5K · 2026-01-31
    • Fishman Peter L.SVP, CFO · American Depositary SharesOther 1 833 · 2026-01-31
    • Fishman Peter L.SVP, CFO · American Depositary SharesOther 1 008 @ $15,42$16K · 2026-01-31

    Short positioning

    513.2Kshares short-5.5% vs prior
    6.44days to cover
    59.6%short of daily vol
    89fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    AMRN.NSCanonical
    NSE (India) · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    AMRNANON:CUSANON:CUSANON:CUSEX21:00cEX21:015EX21:184EX21:1d8EX21:231EX21:3e5EX21:40dPharmaceutical
    This companySectorCustomersSubsidiaries

    Evidence & claims

    From filings & derived data
    • Debt-to-equity (FY 2025-12-31): 0.46xDerived (calculated)
    • Net margin (FY 2025-12-31): -18.2%Derived (calculated)
    • Gross margin (FY 2025-12-31): 56.6%Derived (calculated)
    • Return on equity (FY 2025-12-31): -8.4%Derived (calculated)
    • Return on assets (FY 2025-12-31): -5.8%Derived (calculated)
    • Current ratio (FY 2025-12-31): 3.34xDerived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 11.3%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 55.0%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 55.0%Derived (calculated)
    • Gross profit (YoY) (2025-12-31 vs 2024-12-31): 48.5%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 55.4%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 121.7%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): 45.3%Derived (calculated)
    • R&D expense (YoY) (2025-12-31 vs 2024-12-31): -5.1%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): -6.5%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -5.5%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): -2.1%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 6.2%Derived (calculated)
    • Shareholders' equity (annual): USD 459.28MSEC XBRL filing
    • Interest expense (annual): USD 7KSEC XBRL filing
    • R&D expense (annual): USD 19.81MSEC XBRL filing
    • Revenue (annual): USD 213.65MSEC XBRL filing
    • Operating cash flow (annual): USD 6.73MSEC XBRL filing
    • Operating income (annual): USD -50.17MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-05-15FILING8-K filing →
    2026-04-29FILING10-Q filing →
    2026-04-29FILING8-K filing →
    2026-04-18 00:00 UTCINSIDER24 insider transactions — 2026-04 8 derivative
    2026-04-18INSIDERBonfiglio Patrice Eadon transacted 403 sh American Depositary Shares — Director ~$6k
    2026-04-18INSIDERCohen Paul transacted 838 sh American Depositary Shares — Director
    2026-04-18INSIDERCohen Paul transacted 403 sh American Depositary Shares — Director ~$6k
    2026-04-18INSIDERSterling Louis III transacted 838 sh American Depositary Shares — Director
    2026-04-18INSIDERSterling Louis III transacted 403 sh American Depositary Shares — Director ~$6k
    2026-04-18INSIDEROdysseas Kostas D transacted 838 sh American Depositary Shares — Director
    2026-04-18INSIDEROdysseas Kostas D transacted 403 sh American Depositary Shares — Director ~$6k
    2026-04-18INSIDERSullivan Diane E. transacted 403 sh American Depositary Shares — Director ~$6k
    2026-04-18INSIDERHorn Keith transacted 838 sh American Depositary Shares — Director
    2026-04-18INSIDERHorn Keith transacted 403 sh American Depositary Shares — Director ~$6k
    2026-04-18INSIDERO'Connor Oliver transacted 838 sh American Depositary Shares — Director
    2026-04-18INSIDERO'Connor Oliver transacted 438 sh American Depositary Shares — Director ~$7k
    2026-04-18INSIDERSullivan Diane E. transacted 838 sh American Depositary Shares — Director
    2026-04-18INSIDERBonfiglio Patrice Eadon transacted 838 sh American Depositary Shares — Director
    2026-04-18INSIDERSullivan Diane E. acquired 838 sh Restricted Stock Unit — Director
    2026-04-18INSIDERO'Connor Oliver acquired 838 sh Restricted Stock Unit — Director
    2026-04-18INSIDERHorn Keith acquired 838 sh Restricted Stock Unit — Director
    2026-04-18INSIDEROdysseas Kostas D acquired 838 sh Restricted Stock Unit — Director
    2026-04-18INSIDERSterling Louis III acquired 838 sh Restricted Stock Unit — Director
    2026-04-18INSIDERCohen Paul acquired 838 sh Restricted Stock Unit — Director
    2026-04-18INSIDERBonfiglio Patrice Eadon acquired 838 sh Restricted Stock Unit — Director
    2026-04-10FILINGDEF 14A filing →
    2026-04-01INSIDERFishman Peter L. transacted 125 sh American Depositary Shares — SVP, CFO
    2026-04-01INSIDERFishman Peter L. transacted 62 sh American Depositary Shares — SVP, CFO ~$1k
    2026-04-01INSIDERFishman Peter L. acquired 125 sh Restricted Stock Unit — SVP, CFO
    2026-03-27FILING8-K filing →
    2026-03-02FILING10-K filing →
    2026-02-25FILING8-K filing →
    2026-02-01 00:00 UTCINSIDER10 insider transactions — 2026-02 10 derivative
    2026-02-01INSIDERKetchum Steven B acquired 8.0k sh Restricted Stock Unit — EVP, Chief Scientific Officer
    Showing the 40 most recent of 64 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage